Anti-Cancer Effects of Neocuproine via Copper Chelation in A549 Lung Adenocarcinoma Cells
Experimed · 28.04.2026 · 16 (1) · 1-6
DOI: 10.26650/experimed.1720628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimed, online erschienen am 28.04.2026. Verfasst von Fatma Yeşilyurt und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objective
Neocuproine, a dipyridyl derivative with high affinity for copper ions, was investigated for its effects on human lung adenocarcinoma A549 cells, a key model for lung cancer research. Copper ions play crucial roles in cellular functions, such as angiogenesis and oxidative stress regulation, and their dysregulation is linked to tumor progression. This study evaluated neocuproine’s capacity to inhibit A549 cell proliferation and induce apoptosis, with a focus on pro-inflammatory cytokines and oxidative stress markers.Materials and Methods: To assess the cytotoxic effects of neocuproine, A549 cells were treated with doses ranging from 0.1 to 1000 μM. After 24 hours of incubation, cell viability was assessed using the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Additionally, total antioxidant status (TAS), total oxidant status (TOS), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) levels were quantified using enzyme-linked immunosorbent assay (ELISA).
Results
A reduction in cell viability was observed in a concentration-dependent manner, with notable cytotoxic effects particularly evident at 10 and 100 μM doses. The IC50 of neocuproine was calculated as 31.28 μM (p
Zitieren
APA
Yeşilyurt, F., Akçay, G., Avşaroğlu, R., Çamur, S., Yaman, S., Kaya, Ö., Uzun, S., & Hacımüftüoğlu, A. (2026). Anti-Cancer Effects of Neocuproine via Copper Chelation in A549 Lung Adenocarcinoma Cells. Experimed, 16(1), 1-6. https://doi.org/10.26650/experimed.1720628
Vancouver
Yeşilyurt F, Akçay G, Avşaroğlu R, Çamur S, Yaman S, Kaya Ö, et al. Anti-Cancer Effects of Neocuproine via Copper Chelation in A549 Lung Adenocarcinoma Cells. Experimed. 2026;16(1):1-6. doi:10.26650/experimed.1720628
BibTeX
@article{Yeilyurt2026,
author = {Yeşilyurt, Fatma and Akçay, Güven and Avşaroğlu, Ruken and Çamur, Sena and Yaman, Selma and Kaya, Özge and Uzun, Sevdenur and Hacımüftüoğlu, Ahmet},
title = {Anti-Cancer Effects of Neocuproine via Copper Chelation in A549 Lung Adenocarcinoma Cells},
journal = {Experimed},
year = {2026},
volume = {16},
number = {1},
pages = {1--6},
doi = {10.26650/experimed.1720628}
}
EUVIMED